Literature DB >> 12550768

Allele-specific replication associated with aneuploidy in blood cells of patients with hematologic malignancies.

Avital Korenstein-Ilan1, Aliza Amiel, Shadan Lalezari, Michael Lishner, Lydia Avivi.   

Abstract

We hypothesize that coordination between the two DNA parental sets in somatic cells is essential for the stability of the diploid genome, and that its disruption is associated with the many alterations observed in the various cancerous phenotypes. As coordination between two allelic counterparts is well exemplified by synchrony in replication timing, we examined, in blood cells of patients suffering from various hematologic malignancies, replication patterns of five loci. These loci were three cancer-implicated genes (TP53, AML1, and RB1) and two nontranscribed sequences engaged in chromosome segregation. All five loci normally display synchrony in allelic replication timing. In addition, in order to exemplify an asynchronous mode of allelic replication, we followed the replication of allelic counterparts of an imprinted gene (SNRPN), which is distinguished by its asynchronous mode of allelic replication (allele-specific replication). Allelic replication patterns were studied by fluorescence in situ hybridization (FISH), which has been shown to distinguish between nonreplicated and replicated regions of the genome in interphase cells, based on the structure of the specific hybridization signals that are being detected. Using the FISH replication assay we observed, for all loci which normally exhibit synchrony in allelic replication, loss of synchrony when present in blood cells of patients with hematologic malignancies. The loss of synchrony in allelic replication in patients' cells was accompanied by aneuploidy (chromosome losses and gains), the hallmark of cancer. We were able to reinstate the normal pattern of replication in the patients' cells by introducing an inhibitor of DNA methylation. It thus appears loss of allelic coordination is an epigenetic alteration characterizing cancer, which is easily identified by simple cytogenetic means and has a potential use in both cancer investigation and detection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12550768     DOI: 10.1016/s0165-4608(02)00610-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  13 in total

1.  Alterations in replication timing of cancer-related genes in malignant human breast cancer cells.

Authors:  Andrew Fritz; Seema Sinha; Narasimharao Marella; Ronald Berezney
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

2.  Replication timing aberrations and aneuploidy in peripheral blood lymphocytes of breast cancer patients.

Authors:  Helena Grinberg-Rashi; Samuel Cytron; Zully Gelman-Kohan; Talia Litmanovitch; Lydia Avivi
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

Review 3.  DNA replication timing, genome stability and cancer: late and/or delayed DNA replication timing is associated with increased genomic instability.

Authors:  Nathan Donley; Mathew J Thayer
Journal:  Semin Cancer Biol       Date:  2013-01-14       Impact factor: 15.707

4.  The aberrant asynchronous replication - characterizing lymphocytes of cancer patients - is erased following stem cell transplantation.

Authors:  Arnon Nagler; Samuel Cytron; Maya Mashevich; Avital Korenstein-Ilan; Lydia Avivi
Journal:  BMC Cancer       Date:  2010-05-24       Impact factor: 4.430

Review 5.  Replication timing as an epigenetic mark.

Authors:  Ichiro Hiratani; David M Gilbert
Journal:  Epigenetics       Date:  2009-02-01       Impact factor: 4.528

Review 6.  A new light on DNA replication from the inactive X chromosome.

Authors:  Mirit I Aladjem; Haiqing Fu
Journal:  Bioessays       Date:  2014-04-06       Impact factor: 4.345

7.  Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia.

Authors:  Tyrone Ryba; Dana Battaglia; Bill H Chang; James W Shirley; Quinton Buckley; Benjamin D Pope; Meenakshi Devidas; Brian J Druker; David M Gilbert
Journal:  Genome Res       Date:  2012-05-24       Impact factor: 9.043

8.  Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels.

Authors:  Samuel Cytron; Evgeni Stepnov; Igor Bounkin; Maya Mashevich; Aviva Dotan; Lydia Avivi
Journal:  Clin Epigenetics       Date:  2011-03-29       Impact factor: 6.551

9.  Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients.

Authors:  Zohar A Dotan; Aviva Dotan; Jacob Ramon; Lydia Avivi
Journal:  BMC Cancer       Date:  2008-12-25       Impact factor: 4.430

10.  Microdeletion syndromes disclose replication timing alterations of genes unrelated to the missing DNA.

Authors:  Josepha Yeshaya; Itay Amir; Ayelet Rimon; Jane Freedman; Mordechai Shohat; Lydia Avivi
Journal:  Mol Cytogenet       Date:  2009-03-14       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.